Jump to Navigation

Search form

User login

Facebook Connect

NLA Meetings

Meeting Info

NLA Clinical Lipid Update – Fall 2014

Indianapolis, IN
Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity; Application (Sessions I, IV-V, IX), Knowledge (Keynote lecture, Special Sessions New Lipid Guidelines Perspectives & Vulnerable Blood, Sessions II-III, VI-VIII)

You can view NLA Meeting Highlights from previous confereces.

Pre-Conference Courses:
Venue:
Coming soon

Add

The NLA invites speakers and guests to provide scientific medical opinion, which do not necessarily reflect the policy of the NLA. The schedule and faculty are subject to change.

More information is coming soon...

Plan now for your company to participate in the National Lipid Association’s premier scientific meeting series in 2014. Our meetings provide you with a unique opportunity to reach our target audience of Lipidologists, Cardiologists, Endocrinologists, Primary Care Physicians and Allied Health Professionals involved in dyslipidemia management, as well as our distinguished board and faculty.

Our numerous sponsorship opportunities allow you to connect with our members in a whole new way, providing you with maximum return on your investment. The exhibit hall provides a unique setting for you and your company’s representatives to interact daily with attendees as they study the latest advances in their professions. Exhibiting in Hawaii is an excellent way to showcase your commitment to the NLA. You may take these opportunities to acquaint the attendees with the benefits of your products and services in an intimate setting.

If you are interested in becoming a grant supporter or have any questions regarding exhibit opportunities, please contact the Event Department directly, contact info below.

The Fall Clinical Lipid Update Exhibit Prospectus

 

 

 

Contact Info:
Theresa Henson
Event Coordinator
904-309-6207
thenson@lipid.org

 
More information is coming soon.

More information is coming soon...

More information is coming soon...

2014 SATELLITE SYMPOSIA GUIDELINES

The National Lipid Association (NLA) has established that independently developed and CME/CE certified satellite symposia held in conjunction with the scientific meetings of the NLA are valuable opportunities to provide continuing education for our members. In this regard, we are pleased to offer satellite symposia slots in conjunction with our 2014 NLA Meeting Series.
 
Satellite symposia are non-commercial CME- and CE-certified activities addressing educational needs and performance gaps that complement the NLA scientific program agenda. They may include one or a number of speakers and may cover one or several topics addressing the educational gaps of lipid specialists.
 
The following deadlines and guidelines provide important information about holding a
satellite symposium at an NLA meeting and the process for completing a symposium proposal. Please contact the NLA business development department directly (contact below) should there be any questions or further information required. See you in 2014!
 

DOWNLOAD SATELLITE SYMPOSIA GUIDELINES 2014

 

 

Contact:
Amina Resheidat
Program Coordinator
904-309-6212
aresheidat@lipid.org

0
No votes yet

Saturday, March 15
 
Workshop 1: Lipids on the Front Lines
12:45 - 1:15 PM Interpreting results: is There a Role for Advanced Lipid Testing? Elizabeth J. Jackson, MSN, CNS, CLS, FNLA
1:15 - 1:45 PM Navigating Around the Roadblocks: Lipid Management, Barriers and Byways Randy W. Burden, PharmD, MDiv, PhC, CLS, FNLA
1:45 - 2:15 PM Cardiometabolic Benefits of Low - Intensity Physical Activity Marc Hamilton, PhD
2:15 - 2:45 PM Case Study Wrap Up and Q&A  

 

Workshop 2: Lipid Science and Research
12:45 - 1:15 PM How do we Avoid Faltering in Design of Clinical Trials? Eliot Brinton, MD, FNLA*
1:15 - 1:45 PM Should we Change the Endpoints in Cardiovascular Research Outcomes? Sekar Kathiresan, MD
1:45 - 2:15 PM Framingham and Beyond: Lessons Learned and Future Needs from Key Epidemiologic Studies Nathan D. Wong, PhD
2:15 - 2:45 PM Case Study Wrap Up and Q&A  

 

Please select one workshop. Workshop included in your registration.

Monoclonal Antibodies (mAbs): Three Decades of Innovation and Progress

 
Faculty:

Eli M. Roth MD, FACC, FNLA
Medical Director, Sterling Research Group
Professor of Clinical Medicine, University of Cincinnati

Where: Grand Cypress Ballroom G

When: May 2nd, 2014 at 11:35AM-12:35PM

Brought to you by Sanofi-aventis U.S. and Regeneron Pharmaceuticals, Inc.

KYNAMRO®(mipomersen sodium) injection 200 mg/mL: A Review for Clinicians

Dr. Duell’s special areas of interest include lipid disorders (e.g. high cholesterol), metabolic disorders, homocysteine metabolism, prevention of atherosclerosis (heart disease), diabetes, endocrinology and management of obesity. He currently serves as the director of OHSU’s Metabolic Disorders Clinic. He received his medical degree from OHSU in 1983, and completed his Medicine residency at OHSU and the University of Chicago. He completed his Metabolism, Endocrinology and Nutrition fellowship at the University of Washington in Seattle.

Staff:

P. Barton Duell, MD
Director of the Lipid Disorders Clinic
Director, Lipid-Atherosclerosis Laboratory
Director, LDL Apheresis Unit
Oregon Health and Science University

Where: Grand Cypress G

When:  Friday, May 2nd, 2014 6:00PM-7:00PM

Brought to you by Genzyme.

0
No votes yet



by Dr. Radut.